Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells.

Shikonin, a small-molecule natural product which inhibits the activity of pyruvate kinase M2 (PKM2), has been studied as an anti-cancer drug candidate in human cancer models. Here, our results demonstrate that shikonin is able to sensitize human breast cancer cells to chemotherapy by paclitaxel (tax...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenjuan Li, Joan Liu, Kasey Jackson, Runhua Shi, Yunfeng Zhao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094079&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!